SCHEMBL7499536

SCHEMBL7499536

Cn1cc2cc(-c3cccc4cccnc34)ccc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
CCR1 P32246 2/20 0.40
CCR5 P51681 2/20 0.40
CCR8 P51685 2/20 0.40
METAP2 P50579 1/20 0.40
MMP9 P14780 2/20 0.40
KDM4E B2RXH2 2/20 0.40
GMNN O75496 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
HSP90AA1 P07900 1/20 0.40
MMP2 P08253 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7918759 0.79 POLB (0.67) BRD4NPC1POLBRAB9ACCR1
SCHEMBL22946631 0.76 KDM4E (0.59) CCR1CCR5CCR8METAP2MMP9
SCHEMBL26174483 0.74 DYRK1B (0.55) BRD4TGFBR1
SCHEMBL26977191 0.74 GRM5 (0.40) BRD4HTTGRM5GRM1MAT2A
SCHEMBL18228190 0.74 MAT2A (0.40) KDM4EBRAFGRM5GRM1MAT2A
SCHEMBL9681324 0.73 CCR1 (0.55) BRD4NPC1POLBRAB9ACCR1
SCHEMBL17691832 0.73 CCR1 (0.55) BRD4NPC1POLBRAB9ACCR1
SCHEMBL29654363 0.73 CCR1 (0.55) BRD4NPC1POLBRAB9ACCR1
SCHEMBL17334526 0.72 CCR1 (0.62) BRD4NPC1POLBRAB9ACCR1
SCHEMBL23016267 0.70 BRD4 (0.50) BRD4NPC1POLBRAB9ACCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0873338-A1 QUINOLINE DERIVATIVES AS TYPE IV PHOSPHODIESTERASE INHIBITORS Novartis AG (CH) 1998-10-28 EP disclosed
WO-1997018208-A1 QUINOLINE DERIVATIVES AS TYPE IV PHOSPHODIESTERASE INHIBITORS NOVARTIS AG (CH) 1997-05-22 WO disclosed